市場調查報告書
商品編碼
1458092
全球糖尿病視網膜病變市場規模、佔有率、成長分析,依類型(增殖性糖尿病視網膜病變和非增殖性糖尿病視網膜病變),依管理(抗 VEGF、眼內類固醇注射) - 行業預測 2024-2031Global Diabetic Retinopathy Market Size, Share, Growth Analysis, By Type(Proliferative Diabetic Retinopathy, and Non-proliferative diabetic retinopathy), By Management(Anti-VEGF, Intraocular Steroid Injection) - Industry Forecast 2024-2031 |
2022年,全球糖尿病視網膜病變市場規模為83.0億美元,預計將從2023年的88.3億美元成長到2031年的145.1億美元,在預測期內(2024-2031年)複合年成長率為6.4%。
市場擴張預計將受到多種因素的推動,包括糖尿病發病率上升、人口老化以及與糖尿病相關的失明率上升。此外,人們對糖尿病認知的提高和新產品的推出也促進了市場的成長。糖尿病是一種普遍存在的全球性疾病,其特徵是胰臟無法產生胰島素,導致血糖水平升高並損害視網膜毛細血管,從而導致糖尿病性視網膜病變。高血糖水平和監測不足被認為是視網膜變性的危險因素,但早期發現糖尿病、適當用藥、使用現代工具持續自我監測以及採用健康的生活方式可以減輕視網膜損傷並降低糖尿病視網膜病變的發病率。儘管採取了預防措施,糖尿病視網膜病變仍可能導致不可逆轉的失明,因此需要早期檢測策略,例如 Check Eye 提供的策略,這是一家利用人工智慧篩檢糖尿病視網膜病變的健康科技公司。在英國,糖尿病視網膜病變是導致失明的主要原因之一,凸顯了消費者意識和增加醫療保健支出的重要性。此外,預計到 2050 年,全球老齡化人口將增加兩倍,維持健康的生活方式和定期監測血糖對於降低糖尿病及其併發症的風險至關重要。
Global Diabetic Retinopathy Market size was valued at USD 8.30 billion in 2022 and is poised to grow from USD 8.83 billion in 2023 to USD 14.51 billion by 2031, growing at a CAGR of 6.4% during the forecast period (2024-2031).
The market expansion is expected to be propelled by several factors including the increasing incidence of diabetes, a growing aging population, and the rise in diabetes-related blindness. Additionally, heightened awareness of diabetes and the introduction of new products are contributing to market growth. Diabetes, a prevalent global condition characterized by the pancreas' inability to produce insulin, leads to elevated blood sugar levels and damage to retinal blood capillaries, resulting in diabetic retinopathy. High blood sugar levels and inadequate monitoring are considered risk factors for retinal degeneration, but early detection of diabetes, proper medication, continuous self-monitoring using modern tools, and embracing a healthy lifestyle can mitigate retinal damage and lower the incidence of diabetic retinopathy. Despite preventive efforts, diabetic retinopathy can lead to irreversible blindness, necessitating early detection strategies like those offered by Check Eye, a healthtech company leveraging AI to screen for diabetic retinopathy. In the UK, diabetic retinopathy ranks among the leading causes of blindness, underscoring the importance of consumer awareness and increased healthcare spending. Moreover, with the global aging population projected to triple by 2050, maintaining a healthy lifestyle and regular blood glucose monitoring are imperative to mitigate the risks associated with diabetes and its complications.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Retinopathy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Diabetic Retinopathy Market Segmental Analysis
The global diabetic retinopathy market is segmented based on type, management, and region. Based on type, the market is segmented into proliferative diabetic retinopathy, and non-proliferative diabetic retinopathy. With respect to categorization by management, the market is segmented into anti-VEGF, intraocular steroid injection, laser surgery, vitrectomy. Regionwise, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Diabetic Retinopathy Market
The diabetic retinopathy market is witnessing significant expansion, propelled by augmented investments in healthcare infrastructure, which foster improved healthcare provision and accessibility. Concurrently, concerted endeavors by public and private entities to boost awareness regarding diabetic retinopathy are bolstering market growth. Furthermore, favorable reimbursement conditions and a populace with substantial disposable income are fostering the market's expansion. The demographic shift towards an aging population, coupled with evolving lifestyles, further accelerates the market's growth trajectory.
Restraints in the Global Diabetic Retinopathy Market
The increasing occurrence of diabetic retinopathy is accompanied by insufficient awareness regarding the condition and the necessity of regular eye check-ups among individuals with diabetes. Restricted availability of eye care services, especially in remote or underserved regions, poses obstacles to early detection and prompt intervention.
Market Trends of the Global Diabetic Retinopathy Market
Increasingly acknowledged is the pivotal role of early detection and intervention in addressing diabetic retinopathy, with emphasis shifting towards implementing routine screening initiatives, raising awareness through campaigns, and adopting cutting-edge imaging techniques to facilitate prompt diagnosis, thereby enabling timely therapeutic interventions and more effective disease management.